Company page
Skye Bioscience, Inc.
Skye Bioscience, Inc. is a public company traded under the ticker SKYE in the American market. The company has a market capitalization of approximately $24.9 million. Skye Bioscience focuses on developing innovative therapies, leveraging its expertise in cannabinoid science to address various medical conditions.
- Ticker
- SKYE:NASDAQ
- Asset type
- Stock
- Market cap
- $24.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD